Incoterms (International Commercial Terms), are a set of standardised terms used in international trade to define the responsibilities and obligations of buyers and sellers in the sale of goods. These terms are published by the International Chamber of Commerce (ICC) and are widely used in international contracts.

Using Incoterms in the pharmaceutical industry has both advantages and disadvantages. Here are the pros and cons specific to the pharma industry:

Pros of Using Incoterms in the Pharma Industry:

  1. Clarity and Standardisation: Incoterms provide a standardised set of terms that clearly define the responsibilities and obligations of both the pharmaceutical manufacturer (seller) and the buyer. This is crucial in a highly regulated industry like pharmaceuticals to ensure compliance with quality and safety standards.
  2. Risk Management: Incoterms help allocate risk between the parties involved in the transaction. In the pharmaceutical industry, where product integrity and safety are paramount, clearly defined risk transfer points can be essential.
  3. Compliance: The pharmaceutical industry is subject to numerous regulations and standards. Incoterms can help ensure that the import/export process complies with these regulations, as they specify responsibilities for transportation, packaging, and labeling, among other things.
  4. Cost Efficiency: Incoterms can assist in optimising costs by specifying who is responsible for various expenses, such as transportation, insurance, and customs duties. This can help pharmaceutical companies make informed financial decisions.

Cons of Using Incoterms in the Pharma Industry:

  1. Complexity: Pharmaceutical products often require specialised handling, storage, and transportation due to their sensitivity to temperature and other environmental factors. Incoterms may not always cover these specific requirements, leading to complexities in negotiations.
  2. Regulatory Variations: Pharmaceutical regulations can vary significantly from one country to another. While Incoterms can provide a framework, they may not fully address the nuanced regulatory requirements of each jurisdiction.
  3. Customisation Needs: The pharmaceutical industry often involves custom packaging, labeling, and documentation to meet regulatory requirements. Incoterms might not sufficiently address these unique needs, necessitating additional contract clauses.
  4. Product Integrity: In the pharmaceutical industry, ensuring the integrity and quality of products is paramount. Parties need to carefully consider the chosen Incoterm’s impact on product handling and storage to prevent any compromise in product quality.
  5. Legal Complexity: Incoterms provide a basis for contractual obligations, but they do not cover all aspects of a contract. Parties must still navigate legal complexities, such as intellectual property rights, liability for product defects, and regulatory compliance.

In summary, Incoterms can be beneficial in the pharmaceutical industry by providing clarity, risk management, and cost-efficiency. However, due to the industry’s unique requirements and complex regulations, parties must carefully consider the specific needs of each transaction and may need to complement Incoterms with additional contractual provisions to ensure the safe and compliant transportation and delivery of pharmaceutical products. Consulting with legal and trade experts with expertise in pharmaceuticals can be essential in navigating these complexities effectively.

For any questions get in touch with us or fill in the form below.

I agree to receive other communications from MIAS Pharma. *

By clicking submit, you consent to allow us to store and process the personal info submitted above to process your query.